These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11172494)

  • 41. [New developments in application of laser capture microdissection].
    Yan F; Li ZF
    Ai Zheng; 2004 Jul; 23(7):860-4. PubMed ID: 15248929
    [TBL] [Abstract][Full Text] [Related]  

  • 42. From bio-molecular and technology innovations to clinical practice: focus on ovarian cancer.
    Legge F; Ferrandina G; Scambia G
    Ann Oncol; 2006 Jun; 17 Suppl 7():vii46-8. PubMed ID: 16760291
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Towards the application of proteomics in renal disease diagnosis.
    Vidal BC; Bonventre JV; I-Hong Hsu S
    Clin Sci (Lond); 2005 Nov; 109(5):421-30. PubMed ID: 16232126
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Surface-enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI TOF-MS) and ProteinChip technology in proteomics research.
    Seibert V; Wiesner A; Buschmann T; Meuer J
    Pathol Res Pract; 2004; 200(2):83-94. PubMed ID: 15237917
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Patient-specific protein aggregates in myofibrillar myopathies: laser microdissection and differential proteomics for identification of plaque components.
    Feldkirchner S; Schessl J; Müller S; Schoser B; Hanisch FG
    Proteomics; 2012 Dec; 12(23-24):3598-609. PubMed ID: 23044792
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Oncoproteomics: state-of-the-art.
    Jain KK
    Technol Cancer Res Treat; 2002 Aug; 1(4):219-20. PubMed ID: 12625779
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Proteomic Profiling in the Brain of CLN1 Disease Model Reveals Affected Functional Modules.
    Tikka S; Monogioudi E; Gotsopoulos A; Soliymani R; Pezzini F; Scifo E; Uusi-Rauva K; Tyynelä J; Baumann M; Jalanko A; Simonati A; Lalowski M
    Neuromolecular Med; 2016 Mar; 18(1):109-33. PubMed ID: 26707855
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Proteome-wide analysis of head and neck squamous cell carcinomas using laser-capture microdissection and tandem mass spectrometry.
    Baker H; Patel V; Molinolo AA; Shillitoe EJ; Ensley JF; Yoo GH; Meneses-García A; Myers JN; El-Naggar AK; Gutkind JS; Hancock WS
    Oral Oncol; 2005 Feb; 41(2):183-99. PubMed ID: 15695121
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Laser microdissection: A powerful tool for genomics at cell level.
    Bevilacqua C; Ducos B
    Mol Aspects Med; 2018 Feb; 59():5-27. PubMed ID: 28927943
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Proteomics and laser microdissection.
    McGregor E; De Souza A
    Methods Mol Biol; 2006; 333():291-304. PubMed ID: 16790857
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of proteomics in diagnosis of cancer.
    Jain KK
    Technol Cancer Res Treat; 2002 Aug; 1(4):281-6. PubMed ID: 12625787
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Proteomic analysis of laser-captured paraffin-embedded tissues: a molecular portrait of head and neck cancer progression.
    Patel V; Hood BL; Molinolo AA; Lee NH; Conrads TP; Braisted JC; Krizman DB; Veenstra TD; Gutkind JS
    Clin Cancer Res; 2008 Feb; 14(4):1002-14. PubMed ID: 18281532
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Laser capture microdissection as an aid to ultrastructural analysis.
    Grant K; Jerome WG
    Microsc Microanal; 2002 Jun; 8(3):170-5. PubMed ID: 12539787
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Emerging Affinity-Based Proteomic Technologies for Large-Scale Plasma Profiling in Cardiovascular Disease.
    Smith JG; Gerszten RE
    Circulation; 2017 Apr; 135(17):1651-1664. PubMed ID: 28438806
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Laser-capture microdissection: opening the microscopic frontier to molecular analysis.
    Simone NL; Bonner RF; Gillespie JW; Emmert-Buck MR; Liotta LA
    Trends Genet; 1998 Jul; 14(7):272-6. PubMed ID: 9676529
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Laser-microdissection for cell type- and compartment-specific analyses on genomic and proteomic level.
    Fink L; Kwapiszewska G; Wilhelm J; Bohle RM
    Exp Toxicol Pathol; 2006 Jun; 57 Suppl 2():25-9. PubMed ID: 16581237
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Application and development of purification in cancer genomics research].
    Liu ZQ; Tian YQ
    Ai Zheng; 2004 Nov; 23(11):1357-60. PubMed ID: 15522191
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterization of pepsinogen C as a potential biomarker for gastric cancer using a histo-proteomic approach.
    Melle C; Ernst G; Schimmel B; Bleul A; Kaufmann R; Hommann M; Richter KK; Daffner W; Settmacher U; Claussen U; von Eggeling F
    J Proteome Res; 2005; 4(5):1799-804. PubMed ID: 16212435
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Proteomics in clinical trials and practice: present uses and future promise.
    Azad NS; Rasool N; Annunziata CM; Minasian L; Whiteley G; Kohn EC
    Mol Cell Proteomics; 2006 Oct; 5(10):1819-29. PubMed ID: 16737951
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prostate carcinoma tissue proteomics for biomarker discovery.
    Zheng Y; Xu Y; Ye B; Lei J; Weinstein MH; O'Leary MP; Richie JP; Mok SC; Liu BC
    Cancer; 2003 Dec; 98(12):2576-82. PubMed ID: 14669276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.